Digital Newsletters & Web Publishing · vs · Market & Financial Intelligence Platforms
arXiv vs Clarivate
Structured technology and market comparison · 2026
Direct Feature Comparison
arXiv · vs · Clarivate| Attribute | ARarXiv | CLClarivate |
|---|---|---|
| Market Cluster / Sector | Digital Newsletters & Web Publishing | Market & Financial Intelligence Platforms |
| Business Model / Role | Publisher & Media Owner | Data Provider / Broker |
| Platform Focus | Open-access scholarly preprint repository for global research communities. | Research, library and IP workflow software and data provider. |
| Company Size | 10–49 employees | >5,000 employees |
| Headquarters | United States | United Kingdom |
| Year Founded | 1991 | 2019 |
| Dossier & Alternatives |
Analyze all overlapping signals and tech stacks for arXiv and Clarivate
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between arXiv and Clarivate?
When comparing arXiv and Clarivate, both platforms operate within the Digital Newsletters & Web Publishing and Market & Financial Intelligence Platforms ecosystem. arXiv is positioned as Open-access scholarly preprint repository for global research communities, whereas Clarivate focuses on Research, library and IP workflow software and data provider. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to arXiv and Clarivate?
When evaluating arXiv and Clarivate, enterprise buyers also consider other platforms in Digital Newsletters & Web Publishing and Market & Financial Intelligence Platforms. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of arXiv and Clarivate compare?
arXiv is headquartered in United States (founded in 1991) with 10–49 employees. Clarivate is based in United Kingdom (founded in 2019) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: arXiv vs Clarivate
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
arXiv
Recent Signals
No recent market signals documented for arXiv in the current tracking window.
Clarivate
Recent Signals
- ·SEC APIM&A & Corporate Finance
Clarivate Announces Expiration and Results of Debt Tender Offers
On November 12, 2026, Clarivate Plc filed a Form 8-K under Item 8.01 announcing the expiration and final results of previously initiated cash tender offers for certain debt securities. The tender offers were executed through its wholly-owned subsidiary, Clarivate Science Holdings Corporation. The filing incorporates a press release detailing the conclusion of the debt retirement program, supporting the company's broader balance sheet and capital structure management.
- Clarivate announced the expiration and results of cash tender offers for specific debt securities on November 12, 2026.
- The tender offers were conducted via its wholly-owned subsidiary, Clarivate Science Holdings Corporation.
- Details of the accepted tenders and final debt retirement were released via Exhibit 99.1.
- ·SEC APIM&A & Corporate Finance
Clarivate Announces Cash Tender Offer for Outstanding Subsidiary Debt Securities
On September 17, 2026, Clarivate Plc announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation, launched a cash tender offer to purchase certain of its outstanding debt securities. The transaction represents an active liability management initiative aimed at optimizing the company's capital structure and debt profile. Further financial terms and specific tranches targeted in the tender offer were disclosed via an accompanying press release filed as Exhibit 99.1.
- Clarivate Science Holdings Corporation, a wholly-owned subsidiary of Clarivate Plc, initiated a cash tender offer for selected debt securities on September 17, 2026.
- The filing was submitted under Item 8.01 (Other Events) accompanied by a press release as Exhibit 99.1.
- The corporate action is aimed at liability management and refinancing debt obligations.
- ·SEC APIM&A & Corporate Finance
Clarivate Completes $600M Sale of Life Sciences and Healthcare Unit to Altaris
On October 6, 2026, Clarivate completed the divestiture of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC, pursuant to a July 2026 purchase agreement. Total consideration consists of $500 million in cash at closing (subject to customary working capital and debt adjustments), an unsecured senior note of $75 million issued by a Buyer affiliate, and up to $25 million in deferred consideration payable no later than January 31, 2028 upon conclusion of transition services. Concurrent with the divestment, Henry Levy terminated his role as President of Life Sciences & Healthcare under a separation agreement.
- Clarivate closed the divestiture of its Life Sciences and Healthcare segment to Altaris affiliate Janus Buyer, LP on October 6, 2026.
- Consideration includes $500 million cash at closing, a $75 million unsecured senior note, and $25 million in deferred consideration payable by January 31, 2028.
- Henry Levy stepped down as President, Life Sciences & Healthcare upon closing under a formal separation agreement.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners arXiv and Clarivate share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks
